Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
Condition(s):Uterine Atony; Uterine Tone Disorders; Postpartum HemorrhageLast Updated:August 3, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):Uterine Atony; Uterine Tone Disorders; Postpartum HemorrhageLast Updated:August 3, 2020Withdrawn
Condition(s):Twin; Complicating Pregnancy; Postpartum HemorrhageLast Updated:May 1, 2023Recruiting
Condition(s):HemorrhageLast Updated:September 6, 2019Completed
Condition(s):Uterine Atony With HemorrhageLast Updated:August 1, 2022Completed
Condition(s):Postpartum Hemorrhage; Uterine AtonyLast Updated:May 25, 2022Active, not recruiting
Condition(s):EndometritisLast Updated:September 19, 2012Completed
Condition(s):Cesarean SectionLast Updated:November 16, 2022Completed
Condition(s):Uterine Atony; HypotensionLast Updated:June 29, 2017Completed
Condition(s):Postpartum Hemorrhage; Blood LossLast Updated:June 24, 2021Completed
Condition(s):Bleeding; AnemiaLast Updated:April 10, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.